Periodic Reporting for period 1 - HEPARANIB (Small molecule heparanase inhibitors as anti-metastatic cancer drugs)

One of the major challenges in oncology today is the persistent growth and spread of cancer, even when diagnosed and treated early. Compounding this problem is cancer’s ability to adapt and develop resistance to treatment. As a result, primary therapies, often developed at...